Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
IVF startup GonGlobal raises $1.2M for needle-free fertility treatments backed by Innovation Victoria and RMIT University.
PRIVATESep 02, 2026•5 days ago
Amount Raised
$1.2 Million
Round Type
Seed
AustraliaBiotechnologyHealth Care
Investors
Private InvestorRmit UniversityInnovation Victoria
Description
GonGlobal, a biotech startup developing needle-free IVF treatments, has raised $1.2 million in new funding. The round was backed by Innovation Victoria via its University Innovation Platform, with RMIT University matching $500,000 and a private investor contributing $200,000. The funding will accelerate development of GonGlobal's Ovulair drug delivery system, an inhaled alternative to IVF injections designed to make fertility treatment less invasive and more precise. The company was founded by Ellen Gonda and her father Dr Igor Gonda, inspired by Ellen's personal experience with IVF.
Company Information
Company
GonGlobal
Location
Australia
About
GonGlobal is a biotech startup developing needle-free IVF treatments through an inhaled drug delivery system called Ovulair. The company aims to make fertility treatment less painful, more precise, and more accessible by replacing traditional injections with inhaled alternatives. Founded by Ellen Gonda and her father Dr Igor Gonda, the startup emerged from LaunchVic's JumpStart Studio program and collaborates with RMIT University's research team.
Don't miss GonGlobal's next move
Get an email the moment GonGlobal raises, hires an exec, or expands, usually minutes after it happens.
AustraliaBiotechnologyHealth Care